Publication
Gene therapy products in Canada
In recent years, the incredible promise of gene therapy has become a reality as multiple gene therapy products have come to market.
Global | Publication | October 4, 2018
On October 2nd, 2018 the National Hydrocarbons Agency (ANH) published Addendum No. 3 to the Terms of Reference (TOR) of the so-called Permanent Competitive Procedure – 2018. Addendum No. 3 orders the temporary suspension of the permanent competitive procedure, including the postulation of areas made to date under Section 3.3 of the Terms of Reference. To see our prior bulletin on the TOR, click here, and to see our bulletin on Addendums Numbers 1 and 2 of the TOR, click here.
Do not hesitate to contact us if you have any questions or comments. We will be pleased to discuss and review the topics that you consider appropriate.
Publication
In recent years, the incredible promise of gene therapy has become a reality as multiple gene therapy products have come to market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023